title: Commentary: appropriate cancer chemotherapy for ataxia-telangiectasia patients.
authors.affiliation: Department of Pediatrics, New York Medical College, Valhalla, NY 10595, USA.
authors.forename: C
authors.initials: C
authors.lastname: Sandoval
authors.forename: M
authors.initials: M
authors.lastname: Swift
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001260:Ataxia Telangiectasia / Q000150:complications*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*
chemical_list: D001761:Bleomycin